Phase II study of the combination of daratumumab, ixazomib, pomalidomide, and dexamethasone as salvage therapy in relapsed/refractory multiple myeloma
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2022)
关键词
Combination therapy,myeloma,relapsed/refractory multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要